No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / pharmacology
-
Carcinoma, Squamous Cell / epidemiology
-
Carcinoma, Squamous Cell / etiology*
-
Carcinoma, Squamous Cell / pathology
-
Humans
-
Indoles / adverse effects
-
Indoles / pharmacology*
-
Melanoma / drug therapy*
-
Melanoma / genetics
-
Melanoma / pathology
-
Mutation
-
Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
-
Proto-Oncogene Proteins B-raf / genetics
-
Risk Factors
-
Skin Neoplasms / epidemiology
-
Skin Neoplasms / etiology
-
Skin Neoplasms / pathology
-
Sulfonamides / adverse effects
-
Sulfonamides / pharmacology*
-
Vemurafenib
Substances
-
Antineoplastic Agents
-
Indoles
-
Sulfonamides
-
Vemurafenib
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf